As of November 6, 2026, 4 holders' latest Schedule 13D or 13G filings report owning 5% or more of Accendra Health Inc. The largest reported stake is Coliseum Capital Management, LLC's, at 16.9%. 9 filings are on record since October 2, 2025 (Schedule 13D, November 14, 2025).
Sell to companies like Accendra Health Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Bank Of America Corp · Sole voting: 0 · Shared voting: 1,349,537 · Sole dispositive: 0 · Shared dispositive: 8,270,614 · SCHEDULE 13G, 2026-10-07
- · Holder: Charles Schwab Investment Management Inc · Percent: 4.75% · SCHEDULE 13G/A
- · Holder: Kevin M. Webb · Percent: 5.61% · SCHEDULE 13G
- · Holder: The Vanguard Group · Percent: 0% · SCHEDULE 13G/A
- · Holder: Charles Schwab Investment Management Inc · Percent: 5.24% · SCHEDULE 13G
Accendra Health Inc has 9 Schedule 13D or 13G filings on record since 2025-10-02. 4 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Coliseum Capital Management, LLC | 16.9% | 13,100,807 | SCHEDULE 13D, 2025-11-14 | 2025-11-12 |
| Bank Of America Corp | 10.8% | 8,270,614 | SCHEDULE 13G, 2026-10-07 | 2026-09-30 |
| BlackRock, Inc. | 7.1% | 5,454,051 | SCHEDULE 13G/A, 2025-10-02 | 2025-09-30 |
| 5.61% | 4,287,431 | SCHEDULE 13G, 2026-03-30 | 2026-03-12 | |
| Charles Schwab Investment Management Inc | 4.75% | 0 | SCHEDULE 13G/A, 2026-05-14 | 2026-03-31 |
| Dimensional Fund Advisors LP | 4.5% | 3,507,559 | SCHEDULE 13G/A, 2025-10-09 | 2025-09-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-26 | 2026-03-13 |
Holding shares or following this stake? See who's behind Accendra Health Inc and the warning signs.
Free to see. No signup.
Keep reading
More on Accendra Health Inc and the records around it.
Accendra Health Inc elsewhere on the record
- Leadership changes Sep 2026
- Who owns it
Companies that share a holder
- Coliseum Capital Management, LLC also filed stake reports on 6 other companies: Herc Holdings Inc. (Aug 2026), MasterBrand, Inc. (Aug 2026), Sonos, Inc. (Aug 2026)
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC also filed stake reports on 12 other companies: HAIN CELESTIAL GROUP INC (Aug 2026), MEDIFAST INC (Aug 2026), Service Properties Trust (Aug 2026)
- BANK OF AMERICA CORP /DE/ also filed stake reports on 74 other companies: BlackRock 2037 Municipal Target Term Trust (Nov 2026), TRIMAS CORP (Nov 2026), PIMCO CALIFORNIA MUNICIPAL INCOME FUND (Nov 2026)
Watch Accendra Health Inc
Get an email when Accendra Health Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Accendra Health Inc?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Accendra Health Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Accendra Health Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Bank Of America Corp | 0 | 1,349,537 | 0 | 8,270,614 | SCHEDULE 13G, 2026-10-07 |
The latest filing identifies Accendra Health Inc by CUSIP 690732102 and gives its principal executive office as 4435 WATERFRONT DRIVE, SUITE 300, GLEN ALLEN, VA 23060 (SCHEDULE 13G, 2026-10-07).
Purpose of Transaction (Item 4)
Coliseum Capital Management, LLC
The Reporting Persons acquired the Common Stock for investment purposes, and such purposes were made in the Reporting Persons' ordinary course of business. In pursuing such investment purposes, the Reporting Persons may further purchase, hold, vote, trade, dispose or otherwise deal in the Common Stock at times, and in such manner (including pursuant to hedging transactions), as they deem advisable to benefit from changes in market prices of the Common Stock, changes in the Issuer's operations, business strategy or prospects, or from a sale or merger of the Issuer and evaluate plans and proposals for potential extraordinary transactions involving the Issuer such as potential business combinations, asset sales and financing transactions. To evaluate such alternatives, the Reporting Persons routinely will monitor the Issuer's operations, prospects, business development, management, competitive and strategic matters, capital structure, and prevailing market conditions, as well as alternative investment opportunities, liquidity requirements of the Reporting Persons and other investment considerations. Consistent with their investment research methods and evaluation criteria, the Reporting Persons may discuss such matters with management or directors of the Issuer, other shareholders, industry analysts, existing or potential strategic partners or competitors, legal, investment and financing professionals, sources of credit and other investors. Such factors and discussions may …The first part of Item 4 of the SCHEDULE 13D filed 2025-11-14; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-10-02 | BlackRock, Inc. | 7.1% | SCHEDULE 13G/A |
| 2025-10-09 | Dimensional Fund Advisors LP | 4.5% | SCHEDULE 13G/A |
| 2025-10-30 | The Vanguard Group | 7.71% | SCHEDULE 13G/A |
| 2025-11-14 | Coliseum Capital Management, LLC | 16.9% | SCHEDULE 13D |
| 2026-02-12 | Charles Schwab Investment Management Inc | 5.24% | SCHEDULE 13G |
| 2026-03-26 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-03-30 | Kevin M. Webb | 5.61% | SCHEDULE 13G |
| 2026-05-14 | Charles Schwab Investment Management Inc | 4.75% | SCHEDULE 13G/A |
| 2026-10-07 | Bank Of America Corp | 10.8% | SCHEDULE 13G |
Questions about who owns Accendra Health Inc
Who owns Accendra Health Inc?
On this page, 4 holders' latest ownership filings report 5% or more of Accendra Health Inc: Coliseum Capital Management, LLC (16.9%, Schedule 13D, filed 2025-11-14), Bank Of America Corp (10.8%, Schedule 13G, filed 2026-10-07), BlackRock, Inc. (7.1%, Schedule 13G/A, filed 2025-10-02) and Kevin M. Webb (5.61%, Schedule 13G, filed 2026-03-30).
Who are the largest shareholders of Accendra Health Inc?
By the share each holder's latest filing reports, the largest holders of Accendra Health Inc on this page are Coliseum Capital Management, LLC (16.9%), Bank Of America Corp (10.8%) and BlackRock, Inc. (7.1%).
When did Coliseum Capital Management, LLC buy into Accendra Health Inc?
The filings give report dates, not purchase dates. The earliest filing from Coliseum Capital Management, LLC on this page is the Schedule 13D, filed 2025-11-14, reporting 16.9%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 9 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Accendra Health Inc
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 3, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| September 28, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| September 17, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| August 10, 2026 | Leadership change: Edward A. Pesicka departs, Chief Executive Officer | — | Leadership changes | Source |
| May 15, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
Tools for this story
Each opens in a new tab, filled in for Accendra Health Inc. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.